Graeme Martin

Graeme Martin is the current CIO at ALSA Ventures. Prior to this, they held positions at ARJUNA Therapeutics, DJS Antibodies, and Scioto Biosciences, Inc. Graeme has also served as a Non Executive Director at 3Brain AG and HatchBox Bioconsulting LLC. From 2003 to 2017, they were the President & CEO of Takeda Ventures, Inc. Before that, they worked as the Vice President of CNS Therapeutic Area at Roche from 1996 to 2001 and as a Senior Research Scientist at Glaxo-Wellcome from 1995 to 1996.

Graeme Martin has a Ph.D. in Pharmacology from UCL and a B.Sc. in Pharmacology from the University of Bath.

They work with and Lorna Collings - CFO. Their manager is Alek Safarian, CEO. and Robert Balfour - Investment Director reports to Graeme Martin.